12/22
04:01 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
12/9
04:24 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
02:47 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
06:18 am
fbrx
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/25
07:19 am
fbrx
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
04:01 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
11/21
01:59 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
08:06 am
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
11/14
09:00 am
fbrx
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
Medium
Report
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
11/3
04:01 pm
fbrx
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
Medium
Report
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
10/31
01:03 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
04:01 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules